Mirum Pharmaceuticals (MIRM) Intangibles (2021 - 2026)

Mirum Pharmaceuticals' Intangibles history runs 6 years deep, the most recent figure standing at $254.2 million for Q1 2026.

• In Q1 2026, Intangibles rose 4.23% year-over-year to $254.2 million; the TTM figure through Mar 2026 stood at $254.2 million (up 4.23% YoY), while the FY2025 annual figure was $260.9 million, up 4.44% from the prior year.
• Intangibles for Q1 2026 stood at $254.2 million, down from $260.9 million in the prior quarter.
• The five-year high for Intangibles was $261.8 million in Q2 2024, with the low at $18.5 million in Q1 2022.
• The 5-year median for Intangibles is $243.8 million (2025), against an average of $179.3 million.
• The sharpest annual moves came in 2023 and 2025: Intangibles soared 473.68% in 2023, then slipped 9.34% in 2025.
• Mirum Pharmaceuticals' Intangibles stood at $59.0 million in 2022, then jumped by 329.02% to $252.9 million in 2023, then dropped by 1.23% to $249.8 million in 2024, then advanced by 4.44% to $260.9 million in 2025, then slipped by 2.59% to $254.2 million in 2026.
• Business Quant data shows MIRM's Intangibles at $254.2 million in Q1 2026, $260.9 million in Q4 2025, and $231.9 million in Q3 2025.